Announced Mon, 29 Jun · 18:09 IST
Trading window closed from July 1, 2026 ahead of Q1 FY27 results
Compliance View source PDF
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹1842.50
prior close
₹1860.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.6-0.3-0.6-0.5+0.9+0.2-0.4+0.1-1.8+4.8———
Up moveDown movePending
AI summary
Emcure Pharmaceuticals has closed its trading window from July 1, 2026 under SEBI insider trading rules. Designated persons and their immediate relatives cannot trade in company shares until 48 hours after unaudited Q1 FY27 results are declared. The board meeting date for the results will be announced separately. This is a routine compliance filing and does not contain new financial information.
Likely market impact
Routine insider trading compliance update. No new financials. Q1 FY27 results date will be intimated later.